# **更新日志0.8**

新增S蛋白的氨基酸变异和对应核苷酸变异已经整理底表，原始株核苷酸懒癌犯了查论文时再补。因为要确认变异位点的论文内容，能力有限怕错漏过多，拟每5条更新一次，主思维导图尽量简洁。

因为纯外行，查找论文时时间顺序比较随机，有新内容随时补充。

## **一、Spike_R346K：增加一定的免疫逃逸，增强受体亲和力。R346K影响2类抗体但不是特别显著。虽然R346K距离RBM区域较远，但它也通过类似“蝴蝶效应”的长距离“传导”相互作用增强了BA.1.1 RBD与hACE2的结合亲和力。**
<html>
<body>
<!--StartFragment-->

氨基酸突变 | 突变数量	| 核苷酸突变 | 突变数量	| 备注
--|--|--|--|--
R346K|1,328,834|G22599A|1,330,732|

相关论文：

> **1、变体中的 R346K 突变 SARS-CoV-2 Mu 改变了与 2 类单克隆抗体的相互作用：扰动自由能研究** [**https://doi.org/10.1101/2021.10.12.463781**](https://doi.org/10.1101/2021.10.12.463781)
>
>SARS-CoV-2 的Mu 。 变体最近被世界卫生组织 (WHO) 归类为感兴趣的变体 (VOI)，但目前可用的数据有限 特别值得注意的是位于受体结合域（RBD）中的 R346K 突变。 在当前的研究中，我们进行了扰动自由能 (FEP) 计算，以阐明它对一组中和单克隆抗体 (mAb) 的可能影响，这些单克隆抗体已被证明是大多数其他已知的 COVID-19 变体的强抑制剂。 我们的结果表明，R346K 影响 2 类抗体，但其效果并不那么显着 (0 . 66 kcal/mol)； 换言之， 与RBD的结合减少约3倍 。
>
>The Mu variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the world health organization (WHO) but limited data are available at the moment. In particular, a special attention was given to the R346K mutation located in the receptor binding domain (RBD). In the current study we performed Free energy of perturbation (FEP) calculations to elucidate it possible impact on a set of neutralizing monoclonal antibodies (mAbs) which have been shown to be strong inhibitors of the most other known COVID-19 variants. Our results show that R346K affects the class 2 antibodies but its effect is not so significant (0.66 kcal/mol); i.e. reduces the binding with RBD about 3 times.
>
> **2、人类 ACE2 与当前流通的 Omicron SARS-CoV-2 亚变体 BA.2 和 BA.1.1 具有更高结合亲和力的结构基础** [https ://doi.org/10.1016/j.cell.2022.06.023](https://doi.org/10.1016/j.cell.2022.06.023)
>
>目前流行的 Omicron 亚变种是已知突变数量最多的 SARS-CoV-2 毒株。 在此，我们发现人血管紧张素转换酶 2 (hACE2) 与四个早期 Omicron 亚变体（BA.1、BA.1.1、BA.2 和 BA.3）的受体结合域 (RBD) 具有结合亲和力) 遵循 BA.1.1 > BA.2 > BA.3 ≈ BA.1 的顺序。 hACE2与BA.1.1、BA.2和BA.3的RBD的复杂结构表明，BA.2的hACE2结合亲和力高于BA.1，这与BA.2中不存在G496S突变有关。 BA.1.1中的R346K突变主要通过长程改变影响BA.1.1 RBD/hACE2界面中的相互作用网络，并导致BA.1.1 RBD比BA.1 RBD具有更高的hACE2亲和力。 这些结果揭示了 BA.1.1、BA.2 和 BA.3 RBD 之间不同 hACE2 结合模式的结构基础。
>
>The currently circulating Omicron sub-variants are the SARS-CoV-2 strains with the highest number of known mutations. Herein, we found that human angiotensin-converting enzyme 2 (hACE2) binding affinity to the receptor-binding domains (RBDs) of the four early Omicron sub-variants (BA.1, BA.1.1, BA.2, and BA.3) follows the order BA.1.1 > BA.2 > BA.3 ≈ BA.1. The complex structures of hACE2 with RBDs of BA.1.1, BA.2, and BA.3 reveal that the higher hACE2 binding affinity of BA.2 than BA.1 is related to the absence of the G496S mutation in BA.2. The R346K mutation in BA.1.1 majorly affects the interaction network in the BA.1.1 RBD/hACE2 interface through long-range alterations and contributes to the higher hACE2 affinity of the BA.1.1 RBD than the BA.1 RBD. These results reveal the structural basis for the distinct hACE2 binding patterns among BA.1.1, BA.2, and BA.3 RBDs.
>
>在BA.1 RBD/hACE2复合物中，R346“推动”N450并将相应环的构象改变为hACE2。 然后，同一环上的Y449与hACE2的D38接触( 图4 、 图4A 、4B和4D)。 当R346被K346取代时，它指向相反的一侧，不影响N450，相应的环回弹，Y449不再与hACE2的D38接触。 hACE2的D38指向另一侧，失去与Y449和R498的相互作用( 图4 、 图4A 、4C和4E)，而是与BA.1.1 RBD的R493接触。 因此，BA.1.1 RBD R493与hACE2的E35和D38形成盐桥，并且它还与hACE2的H34形成接触。 此外，BA.1.1 RBD S496 与 hACE2 D38 形成氢键。 因此，这些残基形成一个中心，产生强烈的界面相互作用（ 图4C 和4E）。 综上所述，虽然R346K距离RBM区域较远，但它也通过类似“蝴蝶效应”的长距离“传导”相互作用增强了BA.1.1 RBD与hACE2的结合亲和力（ 图 4E ）。
>
>In the BA.1 RBD/hACE2 complex, R346 “pushes” N450 and changes the conformation of the corresponding loop to hACE2. Then, Y449 on the same loop contacts with D38 of hACE2 (Figure 4, Figure 4A, 4B, and 4D). When R346 was substituted by K346, it points to the opposite side and does not influence N450, the corresponding loop springs back, and the Y449 no longer contacts with D38 of hACE2. D38 of hACE2 points to the other side and loses the interactions with Y449 and R498 (Figure 4, Figure 4A, 4C, and 4E) and contacts with R493 of BA.1.1 RBD instead. Consequently, BA.1.1 RBD R493 forms salt bridges with E35 and D38 of hACE2, and it also forms contacts with H34 of hACE2. In addition, BA.1.1 RBD S496 forms a hydrogen bond with hACE2 D38. Therefore, these residues form a hub that generates strong interface interactions (Figures 4C and 4E). In summary, although R346K is far away from the RBM region, it also enhances the binding affinity of BA.1.1 RBD with hACE2 through long-distance “conduction” interactions like the “butterfly effect” (Figure 4E).
>
>AI总结：R346K突变导致BA.1.1 RBD中的Y449不再与hACE2的D38形成相互作用，而是转而与hACE2的R493形成盐桥，同时R493还与hACE2的E35和D38形成相互作用，增强了整体的结合亲和力。


## **二、Spike_R346T：热门免疫逃逸位点，免疫逃逸和受体亲和双增益**
<html>
<body>
<!--StartFragment-->

氨基酸突变 | 突变数量	| 核苷酸突变 | 突变数量	| 备注
--|--|--|--|--
S:R346T|1,785,695|G22599C|1,787,331|在BA.2.75的衍生突变体中，L452R、K444M、R346T和F486V主要导致中和作用的显着降低

> **从SARS恢复者中合理鉴定强效和广泛的Sarbecovirus中和抗体混合物**[**https://doi.org/10.1016/j.celrep.2022.111845**](https://doi.org/10.1016/j.celrep.2022.111845 )
>
>具体来说，SA55的功效受到Y508H的轻微影响；受G504S的中度影响；受K440E影响较大；并被V503E和G504D逃脱，SA58受到K356T、D339Y和K444N的轻微影响；受T345N、R346Q和R346T中度影响；受E340D影响较大；并被E340K和K444E逃脱。然而，大多数已识别的逃逸突变会导致位于利用ACE2的sarbecovirus中保守位点的表面静电势发生变化。并且在流通中未观察到。值得注意的例外是R346T和K444N/T，它们不保守，最近才出现流通。带有D339H的序列也正在出现，这主要是由BA.2.75及其亚系贡献的。
>
>除了E1组NAbs造成的压力外，D1/D2组NAbs也可以促进这些突变的出现，D1/D2组也受到R346和K444突变的影响。
>
>幸运的是，R346T仅导致SA58活性适度下降。R346和K444上突变的积累可能会进一步影响SA58的中和，但SA55可以有效地中和此类突变体，包括最近出现的RBD上具有趋同突变的变体，例如BQ.1、BQ.1.1和XBB。
>
>SA55+SA58可有效中和所有测试的SARS-CoV-2 Omicron突变体，证明其显着的广度和对逃逸突变的抵抗力。
>
>Specifically, the efficacy of SA55 was slightly affected by Y508H; moderately affected by G504S; strongly affected by K440E; and escaped by V503E and G504D, and SA58 was slightly affected by K356T, D339Y, and K444N; moderately affected by T345N, R346Q, and R346T; strongly affected by E340D; and escaped by E340K and K444E (Figures 4F and S4A). However, most of the identified escaping mutations would lead to changes in surface electrostatic potential located on sites that are conserved across ACE2-utilizing sarbecoviruses (Figures 3A and 3B) and are not observed in circulation. Notable exceptions are R346T and K444N/T, which are not conserved and have emerged recently in circulation (Figures S4B and S4C). Sequences with D339H are also emerging, which is mainly contributed by BA.2.75 and its sublineages.44,45
>
>Besides the pressure caused by NAbs in group E1, the emergence of these mutations can be promoted by NAbs in groups D1/D2, which are also affected by R346 and K444 mutations.1
>
>Fortunately, R346T only causes a moderate drop in SA58 activity. The accumulation of mutations on R346 and K444 may further affect the neutralization of SA58, but SA55 could efficiently neutralize such mutants, including recently emerging variants with convergent mutations on RBD such as BQ.1, BQ.1.1, and XBB.31
>
>SA55+SA58 potently neutralizes all tested SARS-CoV-2 Omicron mutants, demonstrating its noteworthy breadth and resistance against escaping  mutations.

## **三、Spike_K356T 增加免疫逃逸**

<html>
<body>
<!--StartFragment-->

氨基酸突变 | 突变数量	| 核苷酸突变 | 突变数量	| 备注
--|--|--|--|--
S:K356T|147,845|A22629C|148,683|

> **1、通过单克隆抗体疗法产生 SARS-CoV-2 逃逸突变** [https://doi.org/10.1038/s41467-023-37826-w](https://doi.org/10.1038/s41467-023-37826-w)
>
>使用第三剂辉瑞 BioNtech 疫苗 BNT162b2 后 28 天获得的血清进行中和测定 24 （图 4 ）。 与野生型 Delta 相比，服用 3 剂 BNT162B 后，Delta+G446V + Y453F 和 Delta+G446V + L455F 分别观察到 1.9 倍和 1.5 倍下降（ p < 0.0001）； 与野生型 BA.1 相比，BA.1 + P337S、BA.1 + E340K 和 BA.1 + K356T 分别减少了 2 倍、1.2 倍和 3.8 倍（ p < 0.0001， p = 0.0082 且 p < 0.0001）。
>
>Neutralisation assays were performed using serum obtained 28 days following a third dose of Pfizer-BioNtech vaccine BNT162b224 (Fig. 4). Following 3 doses of BNT162B a 1.9-fold and 1.5-fold decrease was observed for Delta+G446V+Y453F and Delta+G446V+L455F respectively, compared to wild-type Delta (p<0.0001); whilst a 2-fold, 1.2-fold and 3.8-fold reduction was seen for BA.1+P337S, BA.1+E340K and BA.1+K356T respectively compared to wild-type BA.1 (p<0.0001, p=0.0082 and p<0.0001).
>
>在此，我们报告了接受 sotrovimab 治疗的患者中 BA.1 逃逸突变的鉴定。 除了 P337 和 E340 残基上发生的突变外，我们还发现了一种新的 K356T 突变。 这些突变消除了 sotrovimab 的结合并因此中和活性。 还发现了 Q493R，这是早期大流行病毒和 BA.4/5 中发现的序列的回复。 这种突变位于 sotrovimab 足迹的远端，对抗体结合没有影响，但据报道会增加对 ACE2 的亲和力。
>
> **2、从SARS恢复者中合理鉴定强效和广泛的Sarbecovirus中和抗体混合物**[https://doi.org/10.1016/j.celrep.2022.111845](https://doi.org/10.1016/j.celrep.2022.111845 )
>
>SA58受到K356T、D339Y和K444N的轻微影响
>
>SA58 was slightly affected by K356T, D339Y, and K444N



